COVID-19是否会加剧乳腺癌筛查和诊断中的种族差异?

IF 1.1 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal of Clinical Imaging Science Pub Date : 2022-06-24 eCollection Date: 2022-01-01 DOI:10.25259/JCIS_26_2022
Kate Yacona, Mariam W Hanna, Sara Niyazi, Smita Sharma, Parlyn Hatch, Mauricio Hernandez, Haley Letter
{"title":"COVID-19是否会加剧乳腺癌筛查和诊断中的种族差异?","authors":"Kate Yacona,&nbsp;Mariam W Hanna,&nbsp;Sara Niyazi,&nbsp;Smita Sharma,&nbsp;Parlyn Hatch,&nbsp;Mauricio Hernandez,&nbsp;Haley Letter","doi":"10.25259/JCIS_26_2022","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Health disparities among minority groups, especially African Americans, can limit their access to quality medical care and lead to disproportionate medical management and disease outcomes. The aim of this study was to compare the COVID-19-related change in mammogram volumes and cancer detection at two affiliated academic breast centers, one that serves a predominantly African American patient population and one that serves a predominantly non-African American patient population.</p><p><strong>Materials and methods: </strong>For the purpose of anonymity, racial demographics were collected and the center with a higher African American patient population was designated as institution A, while the center with a higher non-African American patient population was designated as institution B. Careful selection of the two breast centers was instituted in order to limit the impact of potential confounders other than race.An Institutional Review Board (IRB) exemption was obtained and two Mammography Quality Standards Act (MQSA) reports were generated; one for March 2020 through September 2020, during the height of the COVID-19 pandemic, and one for March 2019 through September 2019 to serve as the pre-pandemic control group. The i2b2 Query Analysis Tool® was used to obtain racial demographic data and compare the percent change in screening and diagnostic mammograms, image-guided biopsies, total cancers diagnosed by imaging, and percent of minimal cancers for both institutions.</p><p><strong>Results: </strong>Screening mammograms and breast cancer detection decreased in 2020 compared to 2019 at both institutions. However, the percent change from 2019 to 2020 was greater at institution A than at institution B. Percent minimal cancers, an indicator of early-stage breast cancer also decreased more drastically at institution A than at institution B. Interestingly, the total number of diagnostic exams and image-guided biopsies increased in 2020 at institution B, whereas both decreased at institution A.</p><p><strong>Conclusion: </strong>The COVID-19 pandemic may lead to worsening racial disparities in breast cancer screening. In an effort to narrow future disparity, it is crucial for radiologists and other health care providers to be aware of this inequality and educate all women on the importance of obtaining routine screening mammography. More studies are needed.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2022-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/b1/JCIS-12-35.PMC9479646.pdf","citationCount":"4","resultStr":"{\"title\":\"Can COVID-19 worsen racial disparities in breast cancer screening and diagnosis?\",\"authors\":\"Kate Yacona,&nbsp;Mariam W Hanna,&nbsp;Sara Niyazi,&nbsp;Smita Sharma,&nbsp;Parlyn Hatch,&nbsp;Mauricio Hernandez,&nbsp;Haley Letter\",\"doi\":\"10.25259/JCIS_26_2022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Health disparities among minority groups, especially African Americans, can limit their access to quality medical care and lead to disproportionate medical management and disease outcomes. The aim of this study was to compare the COVID-19-related change in mammogram volumes and cancer detection at two affiliated academic breast centers, one that serves a predominantly African American patient population and one that serves a predominantly non-African American patient population.</p><p><strong>Materials and methods: </strong>For the purpose of anonymity, racial demographics were collected and the center with a higher African American patient population was designated as institution A, while the center with a higher non-African American patient population was designated as institution B. Careful selection of the two breast centers was instituted in order to limit the impact of potential confounders other than race.An Institutional Review Board (IRB) exemption was obtained and two Mammography Quality Standards Act (MQSA) reports were generated; one for March 2020 through September 2020, during the height of the COVID-19 pandemic, and one for March 2019 through September 2019 to serve as the pre-pandemic control group. The i2b2 Query Analysis Tool® was used to obtain racial demographic data and compare the percent change in screening and diagnostic mammograms, image-guided biopsies, total cancers diagnosed by imaging, and percent of minimal cancers for both institutions.</p><p><strong>Results: </strong>Screening mammograms and breast cancer detection decreased in 2020 compared to 2019 at both institutions. However, the percent change from 2019 to 2020 was greater at institution A than at institution B. Percent minimal cancers, an indicator of early-stage breast cancer also decreased more drastically at institution A than at institution B. Interestingly, the total number of diagnostic exams and image-guided biopsies increased in 2020 at institution B, whereas both decreased at institution A.</p><p><strong>Conclusion: </strong>The COVID-19 pandemic may lead to worsening racial disparities in breast cancer screening. In an effort to narrow future disparity, it is crucial for radiologists and other health care providers to be aware of this inequality and educate all women on the importance of obtaining routine screening mammography. More studies are needed.</p>\",\"PeriodicalId\":15512,\"journal\":{\"name\":\"Journal of Clinical Imaging Science\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2022-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/b1/JCIS-12-35.PMC9479646.pdf\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Imaging Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/JCIS_26_2022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Imaging Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/JCIS_26_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 4

摘要

背景:少数群体,特别是非洲裔美国人之间的健康差距可能限制他们获得高质量医疗保健的机会,并导致不成比例的医疗管理和疾病结局。本研究的目的是比较两个附属学术乳腺中心与covid -19相关的乳房x光检查量和癌症检测的变化,一个主要服务于非洲裔美国人患者群体,另一个主要服务于非裔美国人患者群体。材料和方法:出于匿名目的,收集种族人口统计数据,将非裔美国患者人数较多的中心指定为机构a,而将非裔美国患者人数较多的中心指定为机构b。为了限制种族以外的潜在混杂因素的影响,对两个乳房中心进行了仔细的选择。获得了机构审查委员会(IRB)的豁免,并生成了两份乳房x线摄影质量标准法案(MQSA)报告;一组为2020年3月至2020年9月,在2019冠状病毒病大流行高峰期,另一组为2019年3月至2019年9月,作为大流行前对照组。使用i2b2查询分析工具®获得种族人口统计数据,并比较两家机构筛查和诊断性乳房x线照片、图像引导活检、通过成像诊断的总癌症和最小癌症百分比的变化百分比。结果:与2019年相比,2020年两家机构的乳房x光筛查和乳腺癌检出率均有所下降。然而,从2019年到2020年,A机构的百分比变化大于B机构,A机构的百分比(早期乳腺癌的一个指标)的下降幅度也比B机构大。有趣的是,2020年B机构的诊断检查和图像引导活检总数有所增加,而A机构的这两项都有所减少。为了缩小未来的差距,放射科医生和其他医疗保健提供者必须意识到这种不平等,并教育所有女性接受常规乳房x光检查的重要性。需要更多的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Can COVID-19 worsen racial disparities in breast cancer screening and diagnosis?

Can COVID-19 worsen racial disparities in breast cancer screening and diagnosis?

Can COVID-19 worsen racial disparities in breast cancer screening and diagnosis?

Can COVID-19 worsen racial disparities in breast cancer screening and diagnosis?

Background: Health disparities among minority groups, especially African Americans, can limit their access to quality medical care and lead to disproportionate medical management and disease outcomes. The aim of this study was to compare the COVID-19-related change in mammogram volumes and cancer detection at two affiliated academic breast centers, one that serves a predominantly African American patient population and one that serves a predominantly non-African American patient population.

Materials and methods: For the purpose of anonymity, racial demographics were collected and the center with a higher African American patient population was designated as institution A, while the center with a higher non-African American patient population was designated as institution B. Careful selection of the two breast centers was instituted in order to limit the impact of potential confounders other than race.An Institutional Review Board (IRB) exemption was obtained and two Mammography Quality Standards Act (MQSA) reports were generated; one for March 2020 through September 2020, during the height of the COVID-19 pandemic, and one for March 2019 through September 2019 to serve as the pre-pandemic control group. The i2b2 Query Analysis Tool® was used to obtain racial demographic data and compare the percent change in screening and diagnostic mammograms, image-guided biopsies, total cancers diagnosed by imaging, and percent of minimal cancers for both institutions.

Results: Screening mammograms and breast cancer detection decreased in 2020 compared to 2019 at both institutions. However, the percent change from 2019 to 2020 was greater at institution A than at institution B. Percent minimal cancers, an indicator of early-stage breast cancer also decreased more drastically at institution A than at institution B. Interestingly, the total number of diagnostic exams and image-guided biopsies increased in 2020 at institution B, whereas both decreased at institution A.

Conclusion: The COVID-19 pandemic may lead to worsening racial disparities in breast cancer screening. In an effort to narrow future disparity, it is crucial for radiologists and other health care providers to be aware of this inequality and educate all women on the importance of obtaining routine screening mammography. More studies are needed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Imaging Science
Journal of Clinical Imaging Science RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
2.00
自引率
0.00%
发文量
65
期刊介绍: The Journal of Clinical Imaging Science (JCIS) is an open access peer-reviewed journal committed to publishing high-quality articles in the field of Imaging Science. The journal aims to present Imaging Science and relevant clinical information in an understandable and useful format. The journal is owned and published by the Scientific Scholar. Audience Our audience includes Radiologists, Researchers, Clinicians, medical professionals and students. Review process JCIS has a highly rigorous peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts, affiliations and financial associations such that the published content is not biased.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信